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ABSTRACT 
 
DETERMINANTS OF HEALTH EXPENDITURE IN OECD COUNTRIES AND 
THE INCOME ELASTICITY 
 
Şanlıalp, Gülten 
Master of Economics 
Supervisor: Asst. Prof Ümit Özlale 
 
September, 2008 
 
After Newhouse's seminal paper published in 1977 the determinants of health 
expenditure has been studied both by academia and policymakers. The main result of 
these studies is that income is the most important factor explaining the health 
expenditure. This thesis aims to reveal the non-income determinants of health 
expenditure, the magnitude of the income elasticity of health expenditure in OECD 
countries and to explore whether health expenditure is more elastic in high income 
countries. Health can be seen as a necessity if the income elasticity is below unity 
and as a luxury good if the income elasticity is above unity.  An interpretation of 
health being a luxury good is that health expenditure would increase at a higher rate 
than GDP and the public health sector have high priority among the goals of 
economic and social development. Panel data on GDP per capita, dependency rate 
and the public share in health expenditure have been used to investigate the 
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determinants of total health expenditure per capita of OECD countries for the period 
1975-2006. For a richer analysis linear and log-linear functional forms are employed. 
Linear functional form reveals that 100 US$ increase in GDP per capita raises health 
expenditure per capita by 10.99 US$. Log-linear functional form yields income 
elasticity much higher than unity. After sorting out the OECD countries as high-
income and low-income, it is found that health is more elastic in high-income 
countries.  
 
Keywords: Health Expenditure; Income Elasticity 
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ÖZET 
 
OECD ÜLKELERİNDE SAĞLIK HARCAMASI BELİRLEYİCİLERİ VE 
SAĞLIĞIN GELİR ESNEKLİĞİ 
 
Şanlıalp, Gülten 
Yüksek Lisans, İktisat Bölümü 
Tez Danışmanı: Yrd. Doç. Dr. Ümit Özlale 
 
Eylül, 2008 
 
 Newhouse’un 1977’de yayınlanan ve literatürde yeni ufuk açan makalesinden 
sonra sağlık harcamalarının belirleyicileri hem akademisyenler hem de politika 
belirleyenler tarafından araştırılmıştır. Bu çalışmaların temel sonucu, sağlık 
harcamalarını açıklayan en önemli faktörün gelir olduğudur. Bu tez, OECD 
ülkelerindeki sağlık harcamasının gelir dışındaki belirleyicilerini, sağlık 
harcamasının gelir esnekliğini tahmin etmeyi ve yüksek gelirli ülkelerde sağlık 
harcamasının daha esnek olup olmadığını belirlemeyi amaçlamaktadır. Sağlık, sağlık 
harcamasının gelir esnekliği birin altındaysa gereksinim, üzerindeyse lüks mal olarak 
değerlendirilebilir. Sağlığın lüks mal olması, sağlık harcamasının GSYİH’den daha 
büyük bir oranla artacağı anlamına gelir ve bu da demektir ki kamu sağlık sektörü 
ekonomik ve sosyal gelişim hedeflerinin içinde yüksek öneme sahiptir. 1975-2006 
yılları arasında OECD ülkelerinin sağlık harcamalarının belirleyicilerini bulmak için 
  vi
 
kişi başına GSYİH, nüfusun bağımlılık oranı ve sağlık harcamalarında kamu payı 
verileri kullanılmıştır. Daha zengin bir analiz için linear ve log-linear modeller 
tahmin edilmiştir. Linear modelin sonuçlarına göre, kişi başına GSYİH’de 100 US$ 
artış kişi başına sağlık harcamasını 10.99 US$ artıracaktır. Log-linear modelin 
sonuçlarına göre sağlık harcamasının gelir esnekliği birden büyüktür. OECD ülkeleri, 
kişi başına gelirleri kıyaslanarak düşük ve yüksek gelirli ülkeler olarak sıralandığında 
sağlık harcamasının yüksek gelirli ülkelerde daha esnek olduğu bulunmuştur. 
 
Anahtar Kelimeler: Sağlık Harcaması; Gelir Esnekliği 
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CHAPTER 1 
 
 
INTRODUCTION 
 
 
 
There has been a dense literature that has sought to determine the main 
factors explaining the increase in health expenditure in the recent decades. Early 
studies used cross-sectional regressions (Newhouse, 1977; Parkin et al, 1987.; 
Gerdtham et al., 1992) while more recent ones utilized panel data models (Gerdtham, 
1992; Hitiris and Posnett, 1992; Hansen and King, 1996; Blomqvist and Carter, 
1997; Gerdtham et al. 1998; Roberts, 2000; Bac and Le Pen, 2002). Although the 
original empirical model by Newhouse has been improved, the main result that 
emerges from these studies is largely unaffected: aggregate income appears to be the 
most important factor explaining health care expenditure. However, such studies do 
not reach a consensus about the income elasticity of health expenditure. While some 
studies have found the elasticity coefficient to be greater than one, others have 
reported inelastic estimates. 
 
Most of the studies on the determinants of health care expenditure rely on 
international comparisons based on OECD data. First group of studies (cross-
sectional) explores the relationship between health care expenditure and per capita
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 income, conditional on some country-specific control variables, such as dependency 
rate, urbanization, extent of public sector provision, number of practicing physicians 
and so on. The main results of these studies are the following: aggregate income is 
the most important component of health care expenditure; the inclusion of control 
variables does not affect the explanatory power of GDP and the value of income 
elasticities. Second group of studies exploit the panel structure of the OECD data. 
These studies test the presence of country specific and time specific effects, using a 
relationship similar to that used in cross-sectional studies. The main results of this 
stream of research are the following: aggregate income is the most important 
component of health care expenditure; the inclusion of country-specific control 
variables does not affect the explanatory power of GDP and the value of income 
elasticity; there exists either a country-specific or time specific effect in both random 
and fixed effects model specification.  
 
Most of the OECD countries have experienced a substantial increase in the 
proportion of GDP that they allocate to health spending. For the period 1975 to 2006, 
the ratio of average total health expenditure to average GDP of 18 OECD countries 
rose to 9,52 from 6,69. The most recent health data of OECD countries is available 
for the year 2006. In 2006, average health spending per capita in OECD countries is 
2.824 US$, where Turkey has the lowest health spending per capita with 591 US$ 
and the United States has the highest health spending per capita with 6.714 US$. 
When we look at the public share in total health expenditure, US and Mexico have a 
share below 50% and the remaining OECD countries have above 50% i.e. the main 
source of health funding in all OECD countries except the United States and Mexico 
is public sector. 
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Graph 1. Health expenditure per capita, public and private, OECD countries, 2006 
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Source: OECD Health Data 2008, June 2008.1 
 
The average health spending in 2006 accounted 8.9% across OECD countries. 
The country that spends the most on the health as a share of its economy is the 
United States, which allocated 15,3% of its GDP to health in 2006. Switzerland 
follows with a share of 11.3%, France with a share of 11,1% and Germany with a 
share of 10,6%. Total health spending accounted for 5.7% of GDP in Turkey in 2005 
which is the lowest value among OECD countries.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
1  Data are expressed in US dollars adjusted for purchasing power parities (PPPs), which 
provide a means of comparing spending between countries on a common base.  
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Graph 2. Health expenditure as a share of GDP, OECD countries, 2006 
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Source: OECD Health Data 2008, June 2008.2 
 
 Health spending tends to rise with income; in general, OECD countries with 
higher GDP per capita tend to spend more on health.  As showed in Table 1, Turkey 
has the lowest GDP per capita among OECD countries, and it is not surprising that 
Turkey has the lowest health spending per capita among OECD countries. 
 
Table 1. HE per capita and GDP per capita in OECD countries in 2005 
 Lux. Norway US Ireland Iceland Switz. Canada NL Austria Australia 
HE per capita 4153 4328 6347 3126 3373 4069 3460 3192 3507 2999 
GDP per capita 69984 47620 41674 38061 35736 35500 35065 34724 34104 33950 
  Denmark Sweden Belgium UK Finland Germany Japan France Italy Spain 
HE per capita 3169 3012 3421 2580 2523 3251 2474 3306 2496 2260 
GDP per capita 33543 32770 32077 31580 30502 30495 30310 29784 27853 27720 
  Greece New Z. Korea Czech  Portugal Hungary Slovak Poland Mexico Turkey 
HE per capita 2283 2223 1276 1447 2029 1440 1130 843 724 591 
GDP per capita 25472 24916 21342 20280 19982 17004 15880 13572 11298 10370 
Source: OECD Health Data 2008, June 2008. 
 
 
 
                                                 
2  * indicates that the percentages for 2006 are not available and instead data of year 2005 are 
used. 
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This thesis analyzes the determinants of health expenditure, the magnitude of 
income elasticity of health expenditure in OECD countries. The motivation behind the 
analysis of the determinants of health spending is to identify forces that drive the 
persistent increase in health expenditure.  The motivation behind the analysis of 
income elasticity is that the magnitude of income elasticity tells us whether health is 
a luxury or a necessity. Health can be seen as a luxury good if the responsiveness is 
sensitive to income changes i.e. the income elasticity exceeds unity and as a 
necessity good if the responsiveness is insensitive to income changes i.e. the income 
elasticity is below unity. Another interpretation can be found in Kyriopoulos and 
Soulitotis (2002): “If the income elasticity of health expenditure is less than one, then 
the public health sector does not have a high priority among the goals for social and 
economic development.” If in fact the income elasticity of health expenditure is greater 
than one, then health expenditure would increase at a higher rate than GDP and the 
public health sector have high priority among the goals of economic and social 
development.  
 
To address the issues of determinants of health expenditure and income 
elasticity, this thesis focuses on the demand side of health care. For a richer analysis, 
we applied two functional forms: linear functional form to see the magnitude of 
income effect on health expenditure and log-linear functional form to see the 
magnitude of income elasticity of health expenditure. The variables considered on 
the determinants of the health expenditure are the GDP per capita, dependency rate 
and the public share in health expenditure. The reason for including GDP per capita 
is that it is commonly included as a variable in empirical studies of the factors 
responsible for the rise in health expenditure. The reason for including the variable 
dependency rate is that consumption of health care is not evenly distributed across 
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the various stages of life; young children and seniors make more intensive use of it. 
Denton and Spencer (1975) show that compared with health expenditure for someone 
40 years of age, those for someone 60 years of age are almost twice as high, and 
those for someone 70 years of age are almost three times as high. Likewise, Pollock 
(2000) shows that the ageing of the population will contribute to a rise in health 
expenditure. The results of most empirical studies using international data show a 
positive coefficient for this variable (Hitiris and Ponett, 1992; Hitiris, 1997; 
Casasnovas and Saez,1999; Hitiris, 1999; Atella and Marini, 2006), however some 
studies show a non-significant coefficient (Gerdtham, 1992; Blomqvist and Carter, 
1997; Roberts, 1998; Ariste and Carr, 2001). The reason for including the variable 
public share in health expenditure is that political process and the way in which 
health care is financed may have important implications for the amount of health 
expenditure. There exists some disagreement whether the extent of public finance 
will increase or decrease the level of health expenditure. Leu (1986) contends public 
finance will raise the level of spending so long as the user price to the consumer falls 
(but fees to providers do not) and providers have an incentive to respond to the 
increase in demand by increasing quantity supplied. He provides empirical evidence 
suggesting that "the more governments are involved in providing or financing 
medical care in decentralized health care systems, the higher are health expenditures" 
(Leu, 1986). Earlier studies by Buchanan (1965) and Bird (1970) also suggest that 
the degree of public finance in health care expenditures may serve as a restraint on 
such expenditures.  
 
This thesis contributes to the literature in following points: health care is still 
a luxury in OECD countries, increase in public share increases health expenditure 
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and lastly health expenditure is more elastic in high-income countries i.e. the income 
elasticity of health expenditure for high-income countries is significantly higher than 
the income elasticity of health expenditure for low-income countries. 
 
The rest of the paper is organized as follows. In Chapter 2, we present the 
literature survey and in Chapter 3, we present the data and the methodology we 
employed. Lastly, in Chapter 4 we present our conclusions. 
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CHAPTER 2 
 
 
LITERATURE REVIEW 
 
 
 
After Newhouse (1977)'s seminal paper, the determinants of health 
expenditure has been studied both by academia and policymakers. Bivariate 
regression model by Newhouse (1977) has been followed by several studies that 
employ multivariate regressions. A general characteristic of these studies is the 
importance of national income in explaining health expenditure along with a 
selection of non-income variables. Some of these non-income variables are the 
relative price of health care (ratio of medical CPI to GDP price index), the proportion 
of the population over the age of 65, urbanization rate, the publicly funded 
proportion of health expenditure and supply side variables such as number of 
hospital beds per capita, number of practicing physicians per capita and number of 
nurses per capita. In this section, studies which aim to find out the determinants of 
health expenditure, criticize the methods used and investigate whether there exist 
cointegration between variables will be summarized.  
 
Newhouse (1977) asks the question “what determines the quantity of 
resources a country devotes to medical care?”. In order to answer this question
  9
 
Newhouse uses regression of per capita medical-care expenditure upon per capita 
GDP with a sample of 13 developed countries. As Greece has a markedly lower per 
capita GDP than the rest of the sample he estimates the equation with and without 
Greece. He comes up with an R2 of 0.92 i.e. 92 percent of the variance in per capita 
medical expenditure in the countries can be explained by variation in per capita 
GDP.3  His regression of per capita medical care expenditure on per capita income 
for 13 United Nations countries yields income elasticity greater than one, suggesting 
that health is a luxury good.4  
 
Parkin et al. (1987) replicates the regression of total health care expenditure 
per capita on GDP per capita by using OECD (1985) data. Their results show that the 
income variable is statistically significant, accounting for 87% of the variance in 
health expenditures. Their estimated income elasticity is 1.18 when Turkey is 
excluded and 1.12 when Australia, Iceland, New Zealand, Sweden, Switzerland and 
Turkey are excluded. They criticize the implications drawn from strong relationship 
between national health care expenditures and national income. They argue that 
labeling health care as a luxury good relies upon the application of microeconomic 
analysis to macroeconomic data, and that is not appropriate. They also argue that 
international comparisons are based on Purchasing Power Parity rather than 
exchange rate conversions, underlining the importance of prices as well as quantities 
in the relationship and leading to the conclusion that the aggregate data show health 
care to be a necessity rather than a luxury good.5 
 
                                                 
3  R2 is 0.90 without the Greece observation.  
4  Estimated income elasticity at mean per capita GDP (3416 U.S $) is 1.31.  
5  Estimated income elasticity is 1.12 when both variables are converted to US $ using exchange 
rate, and 0.90 when PPP is used for conversion 
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Gbesemete and Gerdtham (1992) use cross-sectional data for 30 African 
countries to measure the effects of socioeconomic and demographic variables on 
health expenditure where per capita health expenditure is a function of percentage of 
births attended by health staff, per capita GNP, percentage of the population under 15 
years of age, urbanization rate, crude birth rates and per capita foreign aid.6 The 
model is estimated by using a multiple regression analysis. They conduct tests for 
misspecification of the model and against functional misspecifications.7 They 
estimate three equations which differ from each other in terms of explanatory 
variables. Per capita GNP, percentage of births and per capita foreign aid are 
included in all three equations. They include the population under 15 as a percentage 
of total population only in one equation and they report negative coefficient although 
they expect a positive correlation. The urban population as a percentage of total 
population is included in two equations and they report a positive coefficient as 
expected. The crude birth rate is included in only one equation and the results reveal 
that it is not significant. The results of their best fitting model show that only per 
capita GNP, percentage of births and per capita foreign aid are statistically 
significant and carry a positive sign. The results indicate that 10% increase in per 
capita GNP increases health care expenditure by about 1%. This positive association 
between per capita GNP and health care expenditure accords with the results of 
earlier studies. The only difference when compared to the OECD countries is that the 
reported income elasticity for health care is 1.5-2.0 whereas the reported income 
elasticity for the African states is barely 1.07. The coefficient for their proxy variable 
on health care delivery (the percentage of births attended by health staff) indicates 
that 10% increase in the percentage of birth attended by health staff increases health 
                                                 
6  Percentage of births attended by health staff is used as an indirect measure of the extent to which 
health services have reached the people.  
7  Breusch-Pagan’s Chi-squared tests and RESET-test 
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care expenditure by 0.28%. The coefficient for the last significant variable (per 
capita foreign aid) indicates that 10% increase in per capita foreign aid increases 
health care expenditure by 0.18%. 
 
  Gerdtham et al. (1992) concern with an empirical investigation of the factors 
behind the variance in health care expenditure in the OECD countries. They 
generalize a model where health expenditure is a function of national income, 
relative price of health care, institutional factors, age structure and urbanization. 
They use single cross-section of 19 OECD countries in 1987. According to the 
results, the significant regressors are per capita GDP, urbanization, share of public 
financing to total expenditure, share of inpatient care expenditure to total expenditure 
and a dummy variable for countries with fee-for-service as the dominant 
remuneration in outpatient care. They come up with an income elasticity of 1.33, 
which is consistent with previous studies. They also find that 10% increase in the 
share of public health care expenditure will decrease health care expenditure by 
about 5%. Another interesting finding of the paper is that the dummy variable for 
fee-for-service has a significant impact on the health care expenditure; the health 
care expenditure is about 11% higher in countries with fee-for-service as the 
dominant form of remuneration in outpatient care.   
 
  Hitiris and Posnett (1992) analyze the determinants of health expenditure 
using a pooled sample of cross section and time series observations covering 20 
OECD countries for the period 1960-1987; a total of 560 observations. In this study, 
they examine the following relationships: the relationship between per capita health 
spending and per capita GDP, the potential influence of non-income variables (the 
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proportion of the population over 65, the public finance share of total health 
spending, and a set of shift dummies to capture country specific fixed effects) on 
differences in health spending, and lastly the relationship between crude mortality 
rates, GDP per capita and per capita spending on health. First equation produces a 
point estimate of the income elasticity at 1.026 when exchange rate is used for 
adjustment. Adjustment by GDP PPP leads to a higher elasticity at 1.16, however it 
reduces the overall explanatory power of the equation. According to the results of 
second equation, the coefficient of the proportion of population over 65 is significant 
and has the expected sign, with an elasticity of around 0.55. Also results imply that 
inclusion of the variable public finance share of total health spending adds nothing to 
the explanatory power of equation and the variable is not significant. Third equation 
indicates that mortality rates are positively correlated with GDP per capita and 
negatively related to per capita health spending. The conclusion of the paper is that 
the strong positive relationship between per capita health spending and GDP is 
confirmed by a larger sample. Also the importance of some non-income variables is 
confirmed, although the direct impact of such factors appears to be small. 
 
Moore et al. (1992) specifies 3 models for cross-country examination of 
health care spending. Dependent variable in all 3 models is per capita health care 
expenditure. In the first model independent variable is just per capita gross domestic 
income. In the second model per capita health expenditure is a function of per capita 
income and the ratio of public expenditures to total health care expenditures. Third 
model includes control variables for supply across countries, which are number of 
hospital beds per capita, number of practicing physicians per capita and the number 
of nurses per capita. They estimate the models in both linear and double-log 
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functional form with data from 20 OECD countries for the period 1972-1987.  They 
conclude that per capita income is the most important determinant of national health 
care spending as separate regressions revealed that over 90 percent of variation in 
national health care expenditures could be explained by per capita income alone. 
Results regarding the impact of public finance on health care spending are mixed; 
they can not find any empirical support for the hypothesis that publically financed 
health care may serve as a restraint on such expenditures. Furthermore they find that 
the relationship between the share of total health expenditure financed publicly and 
per capita health expenditure is even weaker when supply side variables are included 
in the model. According to the results two of the three supply side variables (number 
of practicing physicians per capita and number of nurses per capita), which serve 
primarily as control variables to minimize the potential omitted variable bias on the 
per capita income variable, do not have statistically significant effects on per capita 
health expenditure. They find that the number of per capita beds has a negative effect 
on health care spending i.e. the per capita supply of hospital beds tends to reduce 
health care expenditures. They also calculate income elasticities and they find that 
health is a necessity in the short-run while a luxury in the long-run; all of the 
estimated short-run  elasticities are significantly less than 1 (around 0.8) whereas all 
of the long-run elasticities are significantly greater than 1 (around 1.3).  
 
Hitiris (1997) focuses on the aggregate determinants of health expenditure in 
European Community countries over the period 1960-1991. Through the equation, 
Hitiris uses per capita GDP, dependency rate (“population aged 0-19 plus 65 and 
over” as per cent of population aged 20- 64, with), share of public expenditure in 
total health spending  and the rate of inflation as independent variables and per capita 
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health expenditure (both public and private) as dependent variable. They apply two 
different methods. First method assumes the cross-sectional units (that is the EC 
member states) independent and considers the disturbance terms cross-sectionally 
heteroscedastic and time-wise autoregressive. Second method assumes the cross-
sectional units interdependent and the disturbance terms correlated and time-wise 
autoregressive. Both equations show a high goodness-of-fit and, with the exception 
of the inflation variable in first method which is non-significant, the estimated 
coefficients are positive and statistically significant. The estimated income elasticity 
is statistically significant and within the range of 1.0-1.2, confirming the findings of 
Hitiris and Posnett (1992), the research for the OECD countries. 
 
Hansen and King (1996) use data of 20 OECD countries for the period 1960-
1987. In the model, dependent variable is real per capita health care expenditure and 
the explanatory variables are real per capita GDP, the proportion of the population 
under the age of 15 and over the age of 65, the proportion health care expenditure 
that is publicly funded and the relative price of health care expenditure. They 
employed country-by-country Augmented Dickey Fuller unit root test in order to 
determine the order of integration of each variable included. According to ADF 
results, two-thirds of the variables tested are non-stationary in levels and no country 
possesses a data set that is entirely stationary in levels. As the next step, they employ 
Engle-Granger cointegration test to determine whether there exists a stationary linear 
relationship between the non-stationary variables. According to Engle-Granger test 
results, for 17 of the 20 countries no evidence of cointegration is found and for two 
of the remaining countries the hypothesis of no cointegration can not be rejected at 5 
% level of significance. The principal finding of the study is that the variables in a 
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standard model of aggregate health care expenditure for 20 members of OECD are 
not collectively stationary in levels, thus one of the key assumptions of OLS is 
violated. However, this finding does not disprove the importance of income in 
determining the level of health care expenditure. 
 
  Blomqvist and Carter (1997) can be seen as a complementary to the paper 
Gerdtham et al. (1992). They use panel data for 18 OECD countries for the period 
1960-1991 to check whether health is a luxury good. As they use the full OECD time 
series data set, they omit many of the institutional and demographic variables 
considered by Gerdtham et al. (1992) and to compensate this drawback they use 
country-specific dummy variables. Variables they used are total health care 
expenditure per capita in PPP terms, GDP per capita in PPP terms, the percentage of 
the population aged 65 years and over, and the implicit price deflator for US GDP 
(1985=100). Their data set exclude Turkey, Luxembourg, New Zealand and Portugal 
as their series are shorter than other counties’ data series. They postulate a log-linear 
relationship between per capita health care spending and real income.  First, they 
apply OLS to annual cross section of the 18 countries at several years as they wonder 
whether they would find estimates of the income elasticity of demand for health care 
significantly above one. Their results seem to support the accepted view that the 
income elasticity of demand for health care is quite a bit larger than one. However 
they realize that the point estimates of the elasticities and intercepts are larger in later 
years. Thus, they analyze individual country series.  They find out that both real per 
capita total health expenditure and income are non-stationary and cointegrated for 
most of the countries. The long-run income elasticity estimated separately for each 
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country turns out to be around or greater than unity for all countries with the 
exception of Canada, UK and the USA.  
 
Casasnovas and Saez (1998) examine the factors involved in rising health 
care expenditures by developing a model using data for 110 regions in eight OECD 
countries in 1997: Australia, Canada, France, Germany, Italy, Spain, Sweden and 
United Kingdom. They argue that the regional factor should be accounted in 
international comparisons as health care is a rather local good in most countries. 
They identify two sources of variation (within countries and between countries) to 
find out if the relationships between health care spending and the explanatory 
variables are country-specific. The relationship is assessed by means of a multilevel 
model. The idea in the study is that the different relationships between health care 
expenditure and its explanatory variables might be country-specific. In the model 
apart from autonomous health care expenditure only income elasticity is country 
specific. The model is specified as a mixed fixed and random coefficients model by 
allowing the constant and the income parameter to differ randomly across countries 
where log of per capita health expenditure depends on log of per capita income, share 
of public health spending and the share of population over the age of 65. They found 
that increases in the percentages of population over 65 and increases in percentages 
of public health expenditures raises health care expenditures. They estimate income 
with very low elasticity and they found that higher (relative) variation in income 
leads to a higher variation in health care expenditure and, consequently, to a higher 
estimated income elasticity.  
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  Hitiris (1999) aimed to search for the common factors which might explain 
the persistent rise in health care expenditures in the G7 countries and the cost 
containment policies. In the model, dependent variable is the total real health 
expenditure per capita (US $ PPP), and the explanatory variables are per capita real 
GDP (US $ PPP), the proportion of the population over age 65 and the share of 
public expenditure on GDP as a proxy for trends in public spending and an indicator 
of government involvement in the economy. The panel data set consists of 35-year 
observations covering the period 1960-1994. The estimation yields high goodness of 
fit (R2=0.839) and the coefficients are statistically significant and have expected 
signs; all explanatory variables (income, ratio of the population over age 65, the 
share of public expenditure on GDP) have positive influence on health expenditure. 
At the point sample means, the income elasticity is 1.07 confirming the dominance of 
GDP in determination of health spending. The proportion of the population over age 
65 has an elasticity of 0.59 which shows that an increase in dependency will raise 
health expenditure. Government expenditure, with an elasticity of 0.27, has positive 
relatively small but statistically significant effects on the growth of health 
expenditure. His findings confirm that income and the share of senior population 
explain almost 90 percent of the variation in health spending.  
 
  Roberts (1999) concentrates on the shortcomings of the analysis of health 
care expenditure done since Newhouse (1977) and employs techniques to analyze the 
determinants of health expenditure as a dynamic heterogeneous data field8 . She uses 
data of 20 OECD countries over the period 1960-1993. She specifies an ADL 
(autoregressive distributed lag) model with random coefficients to capture the 
                                                 
8 Data field is a panel data set consisting of a relatively small number of cross sections, each with a 
relatively long time series dimension. 
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heterogeneity across the OECD countries where total health spending is a function of 
income, proportion of the population over the age of 65, relative price of health care, 
the proportion of publicly funded health spending and a time trend which captures 
technological change. She compares mean group, pooled and cross-section 
estimators. In static mean group and pooled estimation, she finds evidence of 
significant long-run effects of income, the proportion of publicly funded health 
spending and the relative price of health care. According to the results, only the long-
run income elasticity is significant in the dynamic mean group estimation and the 
reported long-run income elasticity is above one. She also focuses on sensitivity 
analysis to check the robustness of the results and the parameter sensitivity to 
country exclusion.  
 
Okunade and Karakus (2001) uses real per capita GDP and relative price of 
health care data of 19 OECD countries covering the period 1960-1997 to explain 
changes in real per capita health expenditures in these countries. In order to 
investigate stationarity of model variables, they employ Augmented Dickey-Fuller 
(ADF) and Phillips-Perron country by country unit root tests and Im, Pesaran and 
Smith (IPS) panel unit root tests. According to the results of ADF and Philips-Perron 
unit root tests, not all of the OECD countries have the same order of integration 
across all the variables. According to IPS test results, panel data reject the unit root 
hypothesis for health care expenditure but not for GDP which implies the correlation 
between health care expenditure and GDP may be spurious in the classical time 
series regression. Also they employ Engle-Granger and Johansen cointegration 
analysis in order to test the presence of long-run relationship. According to the 
results of Engle-Granger cointegration test, data of four countries (Finland, France, 
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Switzerland and the UK) are significantly cointegrated. Results of the Johansen 
multivariate cointegration test differ from those of Engle-Granger method; data of 
Greece, Ireland, and the UK are cointegrated whereas data of other countries seem to 
lack cointegration. A case study for the UK reveals that health is a luxury good with 
income elasticity of 1.43 and the responsiveness of the UK health spending to 
changes in the relative prices is found to be highly elastic. 
 
  Bac and Le Pen (2002) focus on estimating a demand function by using panel 
data for 18 OECD countries for the period 1972-1995 by adopting a cointegration 
approach where per capita health expenditure depends on per capita GDP and the 
relative price of health care. To check if there is a unit root for health care 
expenditure, per capita GDP and the relative price of health care, they apply ADF 
test and IPS panel data unit root test. According to ADF test results, they can not 
reject the null hypothesis of unit root for health care expenditure, per capita GDP and 
relative price of health care series with a few exceptions. According to IPS panel data 
unit root test results they can not reject the hypothesis for health care expenditure and 
per capita GDP however they can reject for the relative price of health care series. In 
order to check stationarity, they apply Hadri panel data stationarity test and 
according to the results they reject the hypothesis of trend stationarity for health care 
expenditure, per capita GDP and relative price of health care. The aim of Bac and Le 
Pen (2002) is to test the hypothesis of cointegration between health care expenditure, 
per capita GDP and the relative price of health care. They found strong evidence on 
the cointegration of these variables and compared OLS, fully modified OLS 
(FMOLS) and dynamic OLS (DOLS) where the latter two estimators account for 
endogeneity and serial correlation. With the FMOLS, health expenditure has income 
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elasticity smaller than one while greater than one with the DOLS. Furthermore, the 
effect of the relative price of health is negative and significant with FMOLS but 
positive and significant with DOLS. So the economic implications of these results 
are quite divergent. 
 
Clemente et al. (2002) examine the stability of health expenditure models in 
the OECD countries for the period 1960-1997 by adopting a cointegration approach. 
They criticize the stability assumption of HE-GDP relationship and argue that there 
exist structural breaks which lead to a biased and incorrect long-run relationship. 
They conduct the analysis by disaggregating total expenditure as public and private 
health expenditure. The results suggest that the inclusion of structural breaks does 
not invalidate income elasticity of health care spending being greater than one.  
 
Gerdtham and Löthgren (2002) aimed to test for cointegration between health 
expenditure and GDP using a different strategy as compared to the previous studies. 
Instead of using single equation models and residual based cointegration tests, they 
adopt a system strategy and use a multivariate heterogeneous panel vector error 
correction model to perform a likelihood-based inference for cointegration rank in 
the health expenditure and GDP system. They perform both country-by-country and 
panel cointegration tests by means of using a panel of 25 OECD countries for the 
period 1960-1997. While the unit root tests indicate that both health expenditure and 
GDP are difference stationary I (1) series, their country-by-country results indicate 
that health expenditure and GDP are cointegrated for 12 of the countries, and for the 
remaining 13 countries the selected rank is zero indicating that the variables are not 
cointegrated. 
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Di Matteo and Di Matteo (1998) focus on the determinants of Canadian 
provincial government health expenditures within pooled time-series cross-section 
framework for the period 1965-1991. Real per capita provincial government 
expenditures on health care are assumed to be a function of real provincial per capita 
income, the proportion of the provincial population over age 65 and real provincial 
per capita federal transfer revenues.  The model specification is log-log so as to 
interpret the coefficients as elasticities. According to the regression results 92% of 
the variation in real per capita provincial government health expenditures is 
explained by the dependent variables and the results show that real per capita 
provincial government health expenditures are positively and significantly related to 
real provincial per capita income, the proportion of the provincial population over 
age 65 and real provincial per capita federal transfer revenue.  They report that the 
income elasticity of government health care spending is 0.77 and therefore imply that 
real per capita provincial government health expenditures are a necessity rather than 
a luxury good. 
 
Di Matteo (2000) focuses on public and private Canadian health expenditures 
over the period 1975-1996. He examines health expenditure as total and sub-
expenditure categories such as hospital, physician and drug spending. In the model 
estimated through the paper, the ratio of public health expenditure to total health 
expenditure is a function of real per capita income, the proportion of the population 
over the age of 65 and real per capita federal government health transfers. Also he 
adds dummy variables for the onset of Established Program Financing, the Canada 
Health and Social Transfer and the Canada Health Act. In order to capture the impact 
of the changing income distribution a variable representing the share of individual 
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income held by the top and bottom quintiles of the income distribution is included. 
The model specification is log-log and the estimation technique is OLS. According to 
the results of the estimation the key determinants of public-private mix are per capita 
income, the share of individual income held by the top quintile of the income 
distribution and federal health transfers. The coefficient for real per capita GDP is 
negative which suggests that public sector expenditure is less income elastic than 
private sector expenditure i.e. increases in per capita income are associated with 
more private health care spending relative to public spending.  
 
In a later study Di Matteo (2003) compares parametric and nonparametric 
estimation methods in estimating the relationship between income and health 
expenditures by using three time series cross section data sets which are U.S state 
level data for the period 1980-1997, Canadian province level data for the period 
1965-2000, and national level data for 16 OECD countries from 1960-1997. Their 
results for parametric OLS estimation for the U.S, Canada and the OECD show that 
per capita health expenditures are positively related to income and the proportion of 
population over age 65 except for the OECD case and federal cash transfers for 
Canada. The income elasticity of health spending evaluated at mean income is 0.70 
for the U.S, 0.72 for Canada and 1.21 for the 16 OECD which means that health care 
is either a luxury or a necessity as income elasticity varies with level of analysis.  
 
Ariste and Carr (2001) try to find answer to what determines the rise in health 
care expenditures in Canada and whether health care represent a luxury good in 
Canada. They use 10 Canadian provinces’ data of total income (disposable personal 
income plus government income), the proportion of the population 65 years of age 
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and over, and the ratio of the deficit or surplus to GDP for 1966 to 1998 to explain 
the real per capita government health expenditures. They examine the non-
stationarity of the variables by using IPS, the cointegrating relationships by using 
Kao’s method and state that variables, both individually and collectively, are non-
stationary and possibly non-cointegrated. They found that the determinants of 
government health expenditures are income, the ratio of the deficit/surplus to GDP 
and a time trend capturing technological progress. The coefficient of the share of 
senior population appears to be statistically insignificant. After concluding that all 
the variables are non-stationary and possibly non-cointegrated, they estimate a fixed 
effects model with non-stationary variables and conclude that the income elasticity of 
government health spending is 0.88. 
 
Atella and Marini (2006) aimed to present new evidence on the relationship 
between income and health care expenditure allowing for substitution and 
complementary relationships between private and public health care expenditure, 
allowing for presence of structural breaks in the dependent variables and lastly 
presence of country-specific health systems. Their analysis is conducted over the 
interval 1960-2000 for 20 OECD countries. Variables they used are per capita health 
expenditure, per capita income, relative price of health care expenditure, dependency 
rate, and the share of government expenditures9. According to the results, in the long 
run and when technology is omitted, income elasticity of total health care 
expenditure is 1.162 for NHS countries and 1.195 for non-NHS countries. In the long 
run and when technology is included, income elasticity of total health care 
                                                 
9  The relative price of health care expenditure is calculated as the ratio of health services price 
index to the GDP deflator, dependency rate is defined as sum of population below 15 and over 64 as 
percentage of population aged 15-64, the share of government expenditure is calculated as the ratio of 
government final consumption expenditure to GDP. 
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expenditure is 0.758 for NHS countries and 0.886 for non-NHS countries. They also 
report the estimated income elasticities with public and private health expenditure 
separation. They state that income elasticity for public health care expenditure and 
for private health care expenditure is higher in NHS countries than non-NHS 
countries. They also note that public expenditure is more dependent on GDP than 
private health care expenditures in the long-run and vice versa in the short-run. 
According to the analysis of the substitution and complementary relationships 
between public and private health care expenditures they report that extra one Dollar 
spent on private health care expenditure in NHS countries private health care 
expenditures decreases by 0.03 Dollars, extra one Dollar spent on public health care 
expenditure in NHS countries private health care expenditures decreases by 0.03 
Dollars. Therefore it is concluded that for NHS countries there exists a substitution 
effect between public and private health care expenditures. For non-NHS countries 
the result is different; in the long-run both private and public health care expenditure 
report complementary relationship. For structural break debate they report that 
income elasticity for public health care expenditure is positively dependent on 
cyclical and long-run components of GDP; the reverse holds for private health care 
expenditure.  
 
The results of most empirical studies summarized above show that income 
elasticity of health expenditure is greater than unity (Newhouse, 1997; Gerdtham et 
al., 1992; Hitiris and Posnett, 1992; Moore et al., 1992; Blomqvist and Carter, 1997; 
Roberts, 1999; Hitiris, 1999; Okunade and Karakus, 2001; Clemente et al., 2002; Bac 
and Lee Pen, 2002). In contrast, some studies show that income elasticity of health 
expenditure is below unity (Casasnovas and Saez, 1998; Di Matteo and Di Matteo, 
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1998; Ariste and Carr, 2001). Studies which include “public share in health 
expenditure” as a country-specific control variable in order to explain changes in 
health expenditure do not reach a concensus. Casasnovas and Saez (1998) and Hitiris 
(1997) find a positive coefficient whereas Gerdtham et al. (1992) find a negative 
coefficient and Hitiris and Posnett (1992) and Moore et al. (1992) find insignificant 
coefficients. The results of most empirical studies including age structure show a 
positive coefficient for this variable (Hitiris and Posnett, 1992; Hitiris, 1997; 
Blomqvist and Carter, 1997; Casasnovas and Saez, 1998, Hitiris, 1999; Atella and 
Marini, 2006). In contrast, Gbesemete and Gerdtham (1992) come up with a negative 
coefficient for the variable “proportion of population under 15” which they used as a 
measure of age structure. Results of other studies including age structure as a 
determinant of health expenditure show a non-significant coefficient for this variable 
(Gerdtham et al., 1992; Roberts, 1999; Ariste and Carr, 2001)
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CHAPTER 3 
 
 
DATA AND ECONOMETRIC METHODOLOGY 
 
 
 
 The postulated model analyzes the determinants of health expenditure among 
OECD countries. We utilize annual OECD health data between the years 1975 and 
2006.  Unfortunately the data series on 12 countries, which are Belgium, Czech 
Republic, France, Greece, Hungary, Italy, Korea, Luxembourg, Mexico, Poland, 
Slovak Republic and Switzerland are excluded from the analysis as they have much 
shorter series than remaining 18 countries.10 Thus, the panel data set consists of 32-
year observations from 18 OECD countries (a sample of 576 observations).  Time 
series used through the model are total health expenditure per capita, GDP per capita, 
dependency rate that is “population aged 0-14 plus 65 and over as percent of 
population aged 15-64” and the public share in total health expenditure. The cross 
section analysis requires the data to have comparable units of measurement across 
countries. For this purpose, we used GDP per capita in US$ PPP and health 
expenditure per capita in US$ PPP values of all countries.
                                                 
10  Australia, Austria, Canada, Denmark, Finland, Germany, Iceland, Ireland, Japan, 
Netherlands, New Zealand, Norway, Portugal, Spain, Sweden, Turkey, United Kingdom and United 
States 
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As there is no common agreement about which functional form to use, in 
order to identify the determinants of health expenditure we estimate the model with 
both the linear functional form (equation 1) and log-linear functional form (equation 
2).  
 
tititititi
uPUBSHPDEPRYHE ,,3,2,1, )()()( ++++= βββα    (1) 
 
 tititititi vPUBSHPDEPRYHE ,,3,2,1, )ln()ln()ln()ln( ++++= ϑϑϑλ   (2) 
 for 18,...,1=i  
 
Dependent variable, HE, is the total health expenditure per capita. The 
explanatory variables are Y, PDEPR and PUBSH where Y is GDP per capita, 
PDEPR is dependency rate and PUBSH is the public share in total health 
expenditure.  
 
3.1. Hausman Test:  
 
First, we need to test whether fixed effect estimation model (versus random 
effect) is appropriate for the relation between health expenditure and explanatory 
variables listed above. The null hypothesis of Hausman’s specification test is that the 
fixed effect and random effect do not differ substantially. Fixed effect model is 
consistent in both null and alternative whereas random effect is consistent under null 
but inconsistent under alternative. In other words, under the null hypothesis both 
OLS in the LSDV (Least Squares Dummy Variable) model and GLS are consistent, 
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but OLS is inefficient, whereas under the alternative, OLS is consistent but GLS is 
not. The chi-squared test is based on the Wald criterion: 
 
][]var[var]'[ 1
∧
−
∧∧
−−−= βββ bbbW  , where b represents coefficients obtained 
from fixed effect model and 
∧
β  represents coefficients obtained from random effect 
model.  
 
1762.501=W   
9715.352=W   
 
Calculated critical 
2χ value is 13.276 for 1% significance level. Both 1W  and 
2W  are much higher than critical
2χ value thus we reject the null hypothesis i.e. 
Hausman test does not support the random effect model. Therefore we conclude that 
fixed effect model is a better model for estimation of health expenditures in OECD 
countries.  
 
3.2. Regression Outputs: 
  
Table 2 presents the estimation results of linear functional form. The 
estimated coefficients of all explanatory variables (GDP per capita, public share in 
health expenditure and dependency rate) satisfy the statistical criteria. The coefficient 
of Y tells us that 100 US$ increase in GDP per capita raises health expenditure per 
capita by 10.99 US$. The coefficient of public share in health expenditure is positive 
which means that the more government is involved in providing or financing medical 
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care the higher are health expenditure. The coefficient of dependency rate is positive 
and it tells us that if the proportion of young children and seniors in the population 
increases the health expenditure of the country rises. 
 
Table 2. Fixed Effect Model Estimation Results “Dependent Variable is HE” 
Variable Constant Y PDEPR PUBSH 
Coefficient -2688.959* 0.109893* 2692.193* 1090.066* 
t-stat (-10.36) (75.92) (9.56) (5.46) 
Note: * indicates significant at 1% significance level.  
 
 Table 3 presents the estimation results of log-linear functional form. The 
estimated coefficients of GDP per capita and public share in health expenditure are 
significant at 1% significance level; however dependency rate turns out to be 
insignificant. Coefficients of GDP per capita and public share in health expenditure 
are positive. The estimated income elasticity of health expenditure is 1.21 and it 
implies that health expenditure is a luxury which is consistent with the literature. 
Studies that find health is a luxury good are the following: Newhouse (1977), 
Gerdtham et al. (1992), Hitiris and Posnett (1992), Blomqvist and Carter (1997), 
Okunade and Karakus (2001), Clemente et al. (2002), Bac and Le Pen (2002).  
 
Table 3. Fixed Effect Model Estimation Results “Dependent Variable is 
ln(HE)” 
Variable Constant ln(Y) ln(PDEPR) ln(PUBSH) 
Coefficient -4.509826* 1.209846* -0.001960 0.359925* 
t-stat (-45.14) (85.88) (-0.02) (6.53) 
Note: * indicates significant at 1% significance level. 
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 In order to see whether the income elasticity of health expenditure in high 
income countries differs from the income elasticity of health expenditure in low 
income countries we categorized 18 OECD countries by means of comparing their 
GDP per capita and labeled Norway, US, Ireland, Iceland, Netherlands, Australia, 
Austria and Denmark as high income countries and labeled Finland, Germany, Japan, 
New Zealand, Portugal, Spain, Sweeden, Turkey and UK as low income countries.  
 
Table 4 presents the results of estimation done for low income countries. The 
estimated coefficients of GDP per capita and public share in health expenditure turn 
out to be significant, however the coefficient of dependency rate turns out to be 
insignificant. The estimated income elasticity for low-income countries is 1.16 which 
means that health is luxury for low-income countries. The coefficient of public share 
in health expenditure is positive likewise the result of the regression done for all 18 
countries. 
 
Table 4. Fixed Effect Model Estimation Results For Low Income Countries 
Variable Constant ln(Y) ln(PDEPR) ln(PUBSH) 
Coefficient -4.68368* 1.158702* -0.801139 0.155236* 
t-stat (-32.31) (61.78) (-6.26) (2.44) 
Lower Bound  1.150005 -1.1332 -0.00984 
Upper Bound  1.2073995 -0.469075 0.3203124 
Note: * indicates significant at 1% significance level. 
 
Table 5 presents the results of estimation done for high income countries. The 
estimated coefficients of all 3 explanatory variables turn out to be significant and 
positive. The estimated income elasticity for high income countries is 1.35 and it tells 
us that health is luxury also for high income countries. The coefficient of dependency 
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rate turns out to be significant this time and it is positive. The coefficient of public 
share in health expenditure is positive as happened in low-income countries meaning 
that increase in public share in health expenditure rises health expenditure in both 
group of countries. 
 
Table 5. Fixed Effect Model Estimation Results For High Income Countries 
Variable Constant ln(Y) ln(PDEPR) ln(PUBSH) 
Coefficient -4.810611* 1.348267* 1.313682* 0.701722* 
t-stat (-44.56) (80.49) (11.22) (5.80) 
Lower Bound  1.304771 1.009649 0.387136 
Upper Bound  1.391763 1.617715 1.016308 
Note: * indicates significant at 1% significance level. 
 
The income elasticity of low-income countries is 1.16, the income elasticity 
of all 18 countries is 1.21 and the income elasticity of high-income countries is 1.35. 
Income elasticities of high-income and low-income countries show that GDP level 
does not change health being a luxury. The upper bound of estimated income 
elasticity of low-income countries is 1.21 and the lower bound of estimated income 
elasticity of high-income countries is 1.30. We reject the hypothesis that income 
elasticity of low-income countries is not different than the income elasticity of high-
income countries. Furthermore, the income elasticity is higher for high-income 
countries than the income elasticity of low-income countries.
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CHAPTER 4 
 
 
CONCLUSION 
 
 
 
This thesis focused on the non-income determinants of health expenditure and 
the magnitude of income elasticity of health expenditure in OECD countries using 
panel data on GDP per capita, dependency rate and public share in health 
expenditure over the period 1975-2006. We estimated the model both with the linear 
and log-linear functional form. According to the results of linear functional form, 
100 US$ increase in GDP per capita rises health expenditure with 10.99 US$. Both 
of the non-income variables are significant and the coefficients are positive. 
According to the results of log-linear functional form the coefficient of ln(Y) which 
implies the income elasticity of health expenditure is 1.21 i.e. health is a luxury good 
for OECD countries. Likewise the result of linear functional form, the coefficient of 
public share in health expenditure turns out to be positive, however the coefficient of 
dependency rate turns out to be insignificant in log-linear functional form.  
 
As a contribution to the literature we grouped OECD countries as high-
income and low-income countries and we estimated the model for low-income and 
high-income countries separately. According to the results, the income elasticity of
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health expenditure for low-income countries is 1.16 whereas it is 1.35 for high-
income countries revealing that health is a luxury good for both low-income and 
high-income countries but health is more income elastic in high-income countries.  
 
As mentioned in the literature review, there is no common agreement about 
the sign of the non-income determinants of health expenditure which are dependency 
rate and public share in health expenditure. According to our results we cannot 
conclude about the sign of the coefficient of dependency rate as it turns out to be 
positive in linear functional form and insignificant in log-linear functional form. On 
the other hand, according to the results of both functional forms the coefficient of 
public share in health expenditure turns out to be positive. Thus we can conclude that 
the more health sector is intervened by governments or the more health expenditure 
is financed by governments the more health expenditures.  
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APPENDIX 1 
 
 
 
Taxonomy of studies on income elasticity of health care expenditure 
Year Author(s) Source Analysis sample size income elasticity 
1977 Newhouse United Nations Cross-section 13 Luxury (>1) 
1992 Gerdtham et al. OECD Cross-section 19 Luxury (>1) 
1992 Gbesemete and 
Gerdtham 
Africa Cross-section 30 Around 1 
1992 Hitiris and Posnett OECD Panel 560 Luxury (>1) 
1992 Moore et al. OECD Panel 384 Necessity (SR), 
Luxury (LR) 
1997 Blomqvist and Carter OECD Panel 744/31 Luxury (>1) 
1998 Casasnovas and Saez OECD Panel 880 Necessity (<1) 
1998 Di Matteo and Di 
Matteo 
Canada Panel 270 Necessity (<1) 
1999 Roberts OECD Panel 660 Around 1 
1999 Hitiris G7 countries Panel 217 Around 1 
2001 Ariste & Carr Canada Panel 330 Necessity (<1) 
2001 Okunade & Karakus OECD Panel 722 Luxury (>1) 
2002 Clemente et al. EU & OECD Panel 185/333/29
6 
Luxury (>1) 
2002 Bac and Le Pen OECD Panel 432 Luxury (>1) 
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APPENDIX 2 
 
 
 
Taxonomy of studies that use public share in health expenditure 
Year Author(s) Source Variable Sign 
1992 Gerdtham et al. OECD Public health exp. / Total health exp. Negative 
1992 Hitiris and Posnett OECD Public health exp. / Total health exp. not 
significant 
1992 Moore et al. OECD Public health exp. / Total health exp. not 
significant 
1998 Casasnovas and Saez OECD Public health exp. / Total health exp. Positive 
1997 Hitiris EC  Public health exp. / Total health exp. Positive 
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APPENDIX 3 
 
 
 
Taxonomy of studies that include age structure 
Year Author(s) Source Variable Sign 
1992 Gbesemete and Gerdtham Africa Proportion of Population under 15 Negative 
1992 Gerdtham et al. OECD Pop. >64 % Pop. 15-64  not significant 
1992 Hitiris and Posnett OECD Proportion of Population over 65 Positive 
1997 Hitiris EC Pop. <20 plus Pop. >64 % Pop. 
20-64 
Positive 
1997 Blomqvist and Carter OECD Proportion of Population over 64 Negative 
1998 Casasnovas and Saez OECD Proportion of Population over 65 Positive 
1999 Hitiris G7  Proportion of Population over 64 Positive 
1999 Roberts OECD Proportion of Population over 64 not significant 
2001 Ariste & Carr Canada Proportion of Population over 64 not significant 
2006 Atella and Marini OECD Pop. <15 plus Pop. >64 % Pop. 
15-64 
Positive 
 
 
 
